FDA approves Nuplazid to treat hallucinations in Parkinson’s disease
3 May 2016 | By Victoria White, Digital Content Producer
The FDA has approved Acadia’s Nuplazid, the first drug approved to treat hallucinations and delusions experienced by some people with Parkinson’s disease...